Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraarterial BMMNC in Subacute Ischemic Stroke
NCT03080571Phase 1Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Jul 2015
- Primary completion
- Dec 2016
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, single-blind trial of autologous bone marrow-derived mononuclear cell in ischemic stroke (2 arms), sponsored by Post Graduate Institute of Medical Education and Research. Primary endpoints: Change in National Institutes of Health Stroke Scale at 6 months, Symptomatic Intracranial Hemorrhage at 6 months and 2 more. Started Jul 2015; status: completed.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT03080571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03080571.